Northern Trust Company of Connecticut’s Novo Nordisk NVO Stock Holding History

Northern Trust Company of Connecticut’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$22.1M	Sell	1,196,370 -92,900	-7%	-$1.62M	0.14%	191
2013 Q3	$21.8M	Buy	1,289,270 +44,700	+4%	+$752K	0.14%	190
2013 Q2	$19.3M	Buy	+1,244,570	New	+$20.7M	0.13%	204

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.42% 1-Year Est. Return

Northern Trust Company of Connecticut's NVO Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Novo Nordisk (NVO) stake by 7.2% in Q4 2013, selling an estimated $1.62M and leaving 1,196,370 shares worth $22.1M. The position accounts for 0.14% of the portfolio, ranked #191.

Northern Trust Company of Connecticut first reported a position in NVO in Q2 2013 and has held it in 3 quarters since. 432 funds tracked by Wall St. Rank hold NVO as of Q4 2013.

Northern Trust Company of Connecticut held 1,196,370 shares of Novo Nordisk worth $22.1M as of Q4 2013.
Northern Trust Company of Connecticut sold 92,900 Novo Nordisk shares in Q4 2013, an estimated $1.62M.
Novo Nordisk made up 0.14% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #191 holding.
Northern Trust Company of Connecticut first reported a position in Novo Nordisk in Q2 2013 and has held it in 3 quarters since.
432 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.